Bravias Capital Group »

iShares NASDAQ Biotechnology Index shares owned by Bravias Capital Group

Quarter-by-quarter ownership of iShares NASDAQ Biotechnology Index (IBB) shares owned by Bravias Capital Group from 13F filings

Historical chart of Bravias Capital Group investment in iShares NASDAQ Biotechnology Index

Tip: Access up to 7 years of quarterly data

All positions including iShares NASDAQ Biotechnology Index held by Bravias Capital Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in iShares NASDAQ Biotechnology Index by Bravias Capital Group

Quarter filed Position value Share count Share price at filing
2025-09-30 $309k 2.1k 144.34
2025-06-30 $264k 2.1k 126.49
2025-03-31 $242k 1.9k 127.88
2024-12-31 $240k 1.7k 138.63

More positions owned by Bravias Capital Group

Ea Series Trust Alpha Arch 1-3 (BOXX)
J P Morgan Exchange Traded F Betabuildrs Us (BBUS)
Vanguard World Inf Tech Etf (VGT)
Cambria Etf Tr Glb Moment Etf (GMOM)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wisdomtree Tr Us Efficient Cor (NTSX)
Vanguard Index Fds Growth Etf (VUG)
Cambria Etf Tr Value Momentum (VAMO)
Ishares Silver Tr Ishares (SLV)
Apple (AAPL)
Wisdomtree Tr Floatng Rat Trea (USFR)
NVIDIA Corporation (NVDA)
Cambria Etf Tr Trinity (TRTY)
Wisdomtree Tr Us Qtly Div Grt (DGRW)
Invesco Qqq Tr Unit Ser 1 (QQQ)

View all positions for Bravias Capital Group

Top funds holding iShares NASDAQ Biotechnology Index

Morgan Stanley
Goldman Sachs Group
Bnp Paribas Arbitrage, Snc
UBS Group
Jpmorgan Chase & Co
Healthcare Of Ontario Pension Plan Trust Fund
Susquehanna International
Commerce Bank N A
Wells Fargo & Company
Royal Bank of Canada
Calamos Advisors
Jane Street
Citadel Advisors
Leucadia National Corporation
Barclays

View all funds holding iShares NASDAQ Biotechnology Index